Masahisa Kitagawa
Präsident bei Teikoku Pharma UK Ltd.
Aktive Positionen von Masahisa Kitagawa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Teikoku Pharma UK Ltd.
Teikoku Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Pharma UK Ltd. manufactures pharmaceuticals. The company is engaged in finding and developing pharmaceuticals in Europe. It is a subsidiary of Teikoku Seikyaku Co. The company also supports the development of Lidoderm, a local anesthetic plaster for the treatment of post herpetic neuralgia. It was founded on February 28, 2001 and is headquartered in London, UK | Präsident | - | - |
Teikoku Seiyaku Co. Ltd.
Teikoku Seiyaku Co. Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan | Direktor/Vorstandsmitglied | 15.11.2013 | - |
Corporate Officer/Principal | - | 15.11.2013 |
Karriereverlauf von Masahisa Kitagawa
Ehemalige bekannte Positionen von Masahisa Kitagawa
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Daiwa Chemical Industries Co., Ltd. | Corporate Officer/Principal | - | - |
Teikoku Pharma USA, Inc.
Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | Vorstandsvorsitzender | 01.06.1997 | - |
Präsident | 01.06.1997 | - |
Ausbildung von Masahisa Kitagawa
University of Tokyo | Undergraduate Degree |
Statistik
International
Japan | 4 |
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
President | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Teikoku Pharma USA, Inc.
Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | Health Technology |
Teikoku Pharma UK Ltd.
Teikoku Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Pharma UK Ltd. manufactures pharmaceuticals. The company is engaged in finding and developing pharmaceuticals in Europe. It is a subsidiary of Teikoku Seikyaku Co. The company also supports the development of Lidoderm, a local anesthetic plaster for the treatment of post herpetic neuralgia. It was founded on February 28, 2001 and is headquartered in London, UK | Health Technology |
Teikoku Seiyaku Co. Ltd.
Teikoku Seiyaku Co. Ltd. Pharmaceuticals: MajorHealth Technology Teikoku Seiyaku Co. Ltd. manufactures and distributes pharmaceuticals. It offers poultices, including Lidoderm, medicated patches and plasters, and anti-inflammatory plasters. The company also provides prescription drugs, such as Dovonex ointment, Hap Star ID, Glycerin Enema, Steronema, Bari-Enema, Magtect U, and Zikilion syrups. Teikoku Seiyaku was founded in 1848 and is headquartered in Higashi Kagawa, Japan | Health Technology |
Daiwa Chemical Industries Co., Ltd. |
- Börse
- Insiders
- Masahisa Kitagawa
- Erfahrung